Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 534
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 101–150 of 1,280 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06769698	A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma	recruiting	Phase 2	120	Regeneron PharmaceuticalsINDUSTRY	5	Aug 21, 2026	clinicaltrials
NCT07778368	A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma	not yet recruiting	Phase 2	20	Shanghai East HospitalOTHER	1	Aug 21, 2026